Eager to dispel doubts about the difficulties of executing Pfizer Inc.’s $68 billion tie-up with Wyeth, Pfizer’s CEO said it will be done more like microsurgery than just stitching two huge corporations together. Jeffrey Kindler has spent two years transforming Pfizer into smaller, entrepreneurial research and marketing business units,...
Read more